Gad Soffer, EVP & Chief Strategy Officer at Atara Biotherapeutics, Inc. (ATRA), sold 9,464 shares at $15.00 ($141K) on 2017-08-15, disclosed to the SEC on 2017-08-17.
Open-market sale of $141k ATRA by EVP & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 7,000 | $105K | 74.6% |
| 2 | $14.53 | 2,464 | $36K | 25.4% |
| Total | $14.88 avg | 9,464 | $141K | 100% |
| Filing → |
| ATRA | SELL | 2017-05-17 | $192K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |
| ATRA | SELL | 2017-02-16 | $334K | — | Filing → |